Symmetrical Versus Asymmetrical Surgery for Asymmetrical Inferior Oblique Overaction

August 5, 2020 updated by: Anuradha Ganesh, Sultan Qaboos University

Symmetrical Versus Asymmetrical Inferior Oblique Muscle Weakening Surgery for Asymmetrical Inferior Oblique Overaction

Overaction of the inferior oblique (IO) muscle is a commonly observed component of childhood strabismus, and is often seen combined with other ocular deviations. It manifests with excessive elevation of the affected eye in adduction, and may cause a pattern strabismus and vertical deviation of the affected eye. IO overaction (IOOA) may be primary or secondary to superior oblique underaction, is often bilateral, and may be symmetrical or asymmetrical.

Surgical management of the overacting IO muscle is often required to achieve ocular alignment. The most commonly performed IO muscle weakening procedures are IO myectomy and graded IO recession. The surgical decision is primarily based on degree of overaction of the IO muscle. Various studies have compared the two IO weakening procedures and have reported a similar success rate for both procedures.

The aim of this study is to compare the effect of two IO weakening procedures (symmetrical vs asymmetrical myectomy or graded recession) in normalizing the IOOA, obtaining vertical alignment and collapse of pattern, when employed in the treatment of asymmetrical IOOA.

Study Overview

Detailed Description

  1. Background (Introduction):

    An excessive elevation of the eyeball on adduction, both on horizontal movement and in upgaze, is often due to inferior oblique over action (IOOA). It is a common disorder of ocular motility, and is usually bilateral and asymmetrical. The asymmetry may be due to difference in time of onset or difference in degree of severity of the IO overaction in the two eyes.

    IOOA may be primary and of unknown etiology, or secondary to a congenital superior oblique palsy. Primary IOOA is commonly associated with congenital esotropia, with the oblique overaction usually presenting after one year of age. In addition to congenital esotropia, primary IO overaction may be associated with exotropia or may occur as an isolated IO overaction without other strabismus.

    IOOA can be isolated or combined with other types of deviations. Primary IOOA has been reported to develop between one to six years of age in up to two-thirds of patients with infantile esotropia, and is usually bilateral. The cause is unknown. IOOA may be seen in 70% of patients with esotropia and in 30% of patients with exotropia. Secondary IOOA is often unilateral and is caused by paresis or paralysis of the superior oblique muscle.

    Depending on severity, IOOA is graded as: (+1) to (+4) overaction. A (+1) overaction indicates slight over elevation in adduction, and (+4) overaction indicates severe over elevation in adduction. It has been suggested that (+1), (+2), (+3) and (+4) overactions roughly translate to 5, 10, 15 and 20 prism diopter (PD) of hypertropia on side gaze.

    Clinically, in addition to the excessive elevation of the eye ball on adduction, IOOA may be associated with "V" pattern of strabismus and vertical deviation in primary position. A "V" pattern is relative divergence on the up gaze and convergence on down gaze. When the eyes converge more than 15 PD from upgaze to downgaze, the "V" pattern is said to be significant. With the eyes in the lateral gaze to the opposite side, alternate cover testing shows that the higher eye refixates with a downward movement and that the lower eye does so with an upward movement.

    Although patients with IOOA present with an excessively elevated eye in adduction, there is little vertical deviation in the primary position, when the condition is bilateral and symmetrical. In contrast, unilateral IOOA or bilateral and asymmetrical IOOA is associated with a significant vertical deviation in the primary position.

    All patients with strabismus undergo full ocular and orthoptic examinations. The angle of strabismus is measured by prisms and alternate cover test for distant and near in primary position of gaze. In distance fixation, the strabismus angle is also measured in secondary positions of gaze to detect presence of pattern deviation or incomitance. Surgery to weaken the IO muscle is indicated when the muscle is overacting and is associated with a significant "V" pattern or vertical deviation.

    There are various surgical techniques for weakening an overacting IO muscle. Most commonly used techniques these days are IO myectomy, graded recession and anteriorization. Normalization of the IOOA, vertical ocular alignment within + 5 PD of orthotropia and collapse of pattern are considered ideal outcomes for the surgery.

    There are many studies comparing IO myectomy and IO recession and all have concluded that they have a similar success rate. However, no study has been conducted to evaluate the effectivity of symmetrical weakening procedures (bilateral myectomy or bilateral equal graded recession) vs asymmetrical procedures (myectomy - recession / bilateral recession of different amounts) in achieving ocular alignment in patients with asymmetrical IOOA. The effect of presence of superior oblique underaction preoperative vertical deviation on the outcome of the surgery has also not been studied to date.

  2. Aim of the study :

    To compare the effect of symmetrical vs asymmetrical Inferior oblique (IO) weakening procedures when employed in the treatment of asymmetrical Inferior oblique over action (IOOA) in :

    Primary objective:

    Normalizing IO action

    Secondary objectives:

    Correcting vertical deviation and "V" pattern

  3. Material and Methods:

    A randomized, interventional clinical trial. All Patients with asymmetrical IOOA, requiring surgical correction (IO weakening procedure) from July 2017 to June 2020 will be prospectively recruited. Prior to surgery all patients will undergo full comprehensive ocular examination, standard orthoptic evaluation and cycloplegic refraction. Minimum of two investigators will assess the preoperative angles of strabismus in a standard manner for each patient. Standard 9-gaze photos will be taken for each patient.

    Standardized surgical procedure will be followed in all patients according to the grade of IOOA, extent of the "V" pattern and the degree of vertical deviation in primary position. Only patients with a minimal period of 3 months of follow up will be selected for analysis.

  4. Randomization:

    Patients will be randomly allocated to symmetrical or asymmetrical surgery using permuted block randomization of sizes 2, 4 or 6 (SAS 9.1.3).

    If symmetrical surgery is planned, then surgical plan for more severe IOOA will be considered for both eyes.

  5. Sample size:

    The study is designed to show that symmetrical surgery is non inferior to asymmetrical surgery. Sample size was estimated considering a study power of 0.8 with an alpha error of 0.05, aiming to detect a difference of 5 PD in the angle of strabismus between the two groups and a postoperative standard deviation (SD) of 5.3. Based on this estimation, a total of 14 patients was found to be adequate in each group.

  6. Statistical analysis:

The baseline quantitative variables will be expressed using mean with SD across the two groups if the distribution of the variables are symmetric. If not, then median with interquartile range will be presented across the groups. The baseline categorical variables will be presented using frequencies and percentages across the groups.

Primary outcomes: The difference in pre- and post-operative measurements (mean and SD) will be calculated for both the groups. The 95% confidence interval (CI) for the difference in change will then be calculated. If there are any clinical differences in the baseline parameters, then analysis of co-variance will be used to compare the change across the groups adjusted for the baseline values. If the lower limit of the CI is within 5 units, then symmetrical surgery will be concluded non-inferior to asymmetrical surgery. Intention to Treat and per-protocol analysis will be done for the primary outcome.

Secondary outcomes: The secondary outcomes will be compared across the groups using independent t-test or Wilcoxon rank sum test depending on the distribution of the continuous variables. Fisher's exact test will be used to compare categorical variables across the groups.

Study Type

Interventional

Enrollment (Anticipated)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Muscat, Oman
        • Recruiting
        • Sultan Qaboos University
        • Contact:
        • Sub-Investigator:
          • Sana Al Zuhaibi, MD
        • Sub-Investigator:
          • Maha Mameesh, MD
        • Sub-Investigator:
          • Sreelatha OK, MSc
        • Sub-Investigator:
          • Majda Al Yahyai, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Comitant esotropia or exotropia with bilateral, asymmetrical IOOA
  • Vertical deviation in primary position < 15 PD
  • Minimum of 3 months follow up

Exclusion Criteria:

  • Paralytic or Restrictive Strabismus
  • Dissociated vertical deviation
  • History of previous IO surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Symmetrical IO weakening.
Same surgery in both eyes
Bilateral IO Myectomy / Bilateral equal graded IO Recession
Active Comparator: Asymmetrical IO weakening.
Different amounts or different surgery in each eye
IO Myectomy in one eye - IO Recession in the fellow eye / Bilateral IO Recession (different amounts) in each eye

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Normalization of IO action
Time Frame: 3 months
To compare effect of symmetrical vs asymmetrical IO weakening in reducing IOOA (scale of +1 to +4)
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vertical ocular alignment
Time Frame: 3 months
To compare the effect of symmetrical vs asymmetrical IO weakening in producing vertical alignment (within 3 PD of orthotropia)
3 months
Collapse of "V" pattern
Time Frame: 3 months
To compare the effect of symmetrical vs asymmetrical IO weakening in collapsing the "V" pattern (difference in deviation in upgaze and downgaze within 5 PD)
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anuradha Ganesh, MD, Sultan Qaboos University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2017

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

December 1, 2020

Study Registration Dates

First Submitted

April 15, 2018

First Submitted That Met QC Criteria

April 15, 2018

First Posted (Actual)

April 25, 2018

Study Record Updates

Last Update Posted (Actual)

August 6, 2020

Last Update Submitted That Met QC Criteria

August 5, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Strabismus

Clinical Trials on Symmetrical IO weakening

3
Subscribe